Recent Advances in Aromatic Hydroxylation to Phenol and Hydroquinone Using H2O2
Catalysts · 17.12.2024 · 14 (12) · 930
DOI: 10.3390/catal14120930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catalysts, online erschienen am 17.12.2024. Verfasst von Evgeny Naranov und 4 weiteren Autor:innen. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Direct hydroxylation of aromatics and phenol processes using green oxidants plays an important role in the petrochemical industry. High selectivity towards hydroquinone is usually hard to achieve due to catechol formation and catalyst deactivation. Herein, we showed the recent studies devoted to selective phenol hydroxylation via oxidation using H2O2. This review summarizes progress that has been achieved in this area. Briefly, aromatic hydroxylation on heterogeneous catalysts, phenol hydroxylation on Ti-containing and supported catalysts, photocatalytic hydroxylation, and new approaches toward phenol hydroxylation have been reviewed.
Förderung
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Naranov, E., Ramazanov, D., Agliullin, M., Sinyashin, O., & Maximov, A. (2024). Recent Advances in Aromatic Hydroxylation to Phenol and Hydroquinone Using H2O2. Catalysts, 14(12), 930. https://doi.org/10.3390/catal14120930
Vancouver
Naranov E, Ramazanov D, Agliullin M, Sinyashin O, Maximov A. Recent Advances in Aromatic Hydroxylation to Phenol and Hydroquinone Using H2O2. Catalysts. 2024;14(12):930. doi:10.3390/catal14120930
BibTeX
@article{Naranov2024,
author = {Naranov, Evgeny and Ramazanov, Dzhamalutdin and Agliullin, Marat and Sinyashin, Oleg and Maximov, Anton},
title = {Recent Advances in Aromatic Hydroxylation to Phenol and Hydroquinone Using H2O2},
journal = {Catalysts},
year = {2024},
volume = {14},
number = {12},
pages = {930},
doi = {10.3390/catal14120930}
}
EUVIMED